Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Addict Biol. 2015 Mar 6;21(4):915–923. doi: 10.1111/adb.12230

Table 1.

Genetic risk score for dopamine-based neurotransmission

Gene Polymorphism Genotype Risk-score
DRD2/ANKK1 rs1800497 AA 1
AG .5
GG 0
DRD2 rs1076560 A-allele carriers 1
GG 0
DRD2 rs4648317 A-allele carriers 1
GG 0

DRD3 rs6280 CC 1
T-allele carriers 0
DRD4 VNTR 7-repeat carriers 1
Not 7-repeat carriers 0
COMT rs4680 GG 1
A-allele carriers 0
DAT1/SLC6A3 VNTR 10/10 1
9-repeat carriers 0
DBH rs2519152 C-allele carriers 1
TT 0
DBH rs1611115 C-allele carriers 1
TT 0
DBH rs1108580 GG 1
A-allele carriers 0

Note. 1 indicates high risk, .5 intermediate risk, 0 low risk.